Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer-Reference-Cited by-同舟云学术

Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer

Published:2023-06 Issue: Volume:92 Page:104633
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Ghiringhelli François,Bibeau Frederic,Greillier Laurent,Fumet Jean-David,Ilie Alis,Monville Florence,Laugé Caroline,Catteau Aurélie,Boquet Isabelle,Majdi Amine,Morgand Erwan,Oulkhouir Youssef,Brandone Nicolas,Adam Julien,Sbarrato Thomas^ORCID,Kassambara Alboukadel,Fieschi Jacques,Garcia Stéphane,Lepage Anne Laure,Tomasini Pascale,Galon Jérôme

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference41 articles.

1. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives;Imyanitov;Crit Rev Oncol Hematol,2021

2. FDA approval summary: pembrolizumab, atezolizumab, and cemiplimab-rwlc as single agents for first-line treatment of advanced/metastatic PD-L1 high NSCLC;Akinboro;Clin Cancer Res,2022

3. PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: a pairwise meta-analysis;García-González;J Clin Med,2020

4. Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer;Shirasawa;Eur J Cancer,2022

5. Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT);Tufman;Lung Cancer,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition;npj Precision Oncology;2024-08-13

2. Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study;Journal of Clinical Oncology;2024-08-01

3. Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology;Briefings in Bioinformatics;2024-07-25

4. Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans;2024-07-16

5. A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue;ACS Sensors;2024-06-05